Almujtama Alraida Medical Co. (9592.SR)

SAR 31.95

(2.4%)

EBITDA Summary of Almujtama Alraida Medical Co.

  • Almujtama Alraida Medical Co.'s latest annual EBITDA in 2023 was 19.53 Million SAR , down -59.09% from previous year.
  • Almujtama Alraida Medical Co.'s latest quarterly EBITDA in 2024 Q2 was 23.12 Million SAR , up 34.91% from previous quarter.
  • Almujtama Alraida Medical Co. reported an annual EBITDA of 47.74 Million SAR in 2022, up 41.63% from previous year.
  • Almujtama Alraida Medical Co. reported an annual EBITDA of 34.51 Million SAR in 2021, down 0.0% from previous year.
  • Almujtama Alraida Medical Co. reported a quarterly EBITDA of 26.8 Million SAR for 2023 Q2, up 0.68% from previous quarter.
  • Almujtama Alraida Medical Co. reported a quarterly EBITDA of 16.61 Million SAR for 2023 Q4, down -38.0% from previous quarter.

Annual EBITDA Chart of Almujtama Alraida Medical Co. (2023 - 2021)

Historical Annual EBITDA of Almujtama Alraida Medical Co. (2023 - 2021)

Year EBITDA EBITDA Growth
2023 19.53 Million SAR -59.09%
2022 47.74 Million SAR 41.63%
2021 34.51 Million SAR 0.0%

Peer EBITDA Comparison of Almujtama Alraida Medical Co.

Name EBITDA EBITDA Difference
Middle East Pharmaceutical Industries Co. 85.13 Million SAR 77.057%
Al-Dawaa Medical Services Company 830.43 Million SAR 97.648%
Nahdi Medical Company 1.64 Billion SAR 98.812%
Al-Razi Medical Co. 5.64 Million SAR -245.718%